NDC 73650-316

TZIELD

Teplizumab-mzwv

TZIELD is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Provention Bio, Inc.. The primary component is Teplizumab.

• Product ID: 73650-316_5550ff66-7142-42ad-8a7c-f29668d47c3b
• NDC: 73650-316
• Product Type: Human Prescription Drug
• Proprietary Name: TZIELD
• Generic Name: Teplizumab-mzwv
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-11-17
• Marketing Category: BLA /
• Application Number: BLA761183
• Labeler Name: Provention Bio, Inc.
• Substance Name: TEPLIZUMAB
• Active Ingredient Strength: 1 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 73650-316-01

1 VIAL, SINGLE-DOSE in 1 CARTON (73650-316-01) > 2 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2022-11-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details